Greg Yap

Aimmune Therapeutics is a biopharmaceutical company developing and bringing new treatments to people with potentially life-threatening food allergies.

Benchling is a life sciences R&D cloud platform helping the next generation of scientists make breakthrough discoveries faster than ever before.

Cartwheel is a tech-enabled provider for youth mental health services, helping schools and families tackle the student mental health crisis.

Clear Labs offers the only automated next-generation sequencing platform for applications including COVID diagnostics and food safety testing.

Cofactor Genomics is a biotech company whose mission is to enable drug development, medical research, and personalized medicine using RNA-based information and technologies.

Curie.Bio is a seed-stage venture firm and therapeutics accelerator focused on helping founders launch viable therapeutics companies.

Delfi is developing a revolutionary test for early detection of cancer using machine learning on DNA in the blood.

Earli’s mission is to make cancer a benign experience, by catching and curing it early.

Encoded Therapeutics, a precision gene therapy company, is developing genomics-driven medicines that have the potential to transform the treatment paradigm for severe genetic disorders.

Epiodyne is developing breakthrough opioid medicines to manage pain and treat opioid use disorder (OUD) with minimal potential for addiction and safety risks.

Genesis Therapeutics is pioneering AI technologies to create medicines for patients with severe and unmet medical needs.

H1's health data platform supports the end-to-end therapeutic development process of medical companies and healthcare systems.

Koala is a modern pet healthcare provider with a mail order pharmacy offering for pet medications.

Ophelia is reinventing drug rehab by making evidence-based treatment private, affordable, and accessible via telemedicine.

Particle Health is an API designed for healthcare innovators that gives access to vital medical data.

Pliant Therapeutics is focused on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

Recursion is discovering transformative new treatments by combining automation, machine learning, and the world’s largest biological image datasets.

Riva Health provides a digital cardiology platform designed to give patients a comprehensive, equitable, and accessible way to manage hypertension and heart disease.

Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying causes of genetic disorders.

Led by pioneers in synthetic biology and computation, Senti is pioneering new technology platforms to design synthetic gene circuits for adaptive cell and gene therapies.

Vilya is creating a novel class of medicines to treat disease targets inside cells, leveraging its proprietary AI engine to design for drug-like properties and ultimately generate new drug candidates.

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease.